Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrogen Peroxide for Placental Site Bleeding in PAS
NCT06030492Unknown
- Sponsor
- Cairo University
- Start
- Jan 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of hydrogen peroxide in Placenta accreta spectrum (PAS) and placenta previa (2 arms), sponsored by Cairo University. Primary endpoint: Control of intra-operative bleeding from placental bed. Status: unknown.
02
Drugs
hydrogen peroxide
03
Conditions
Placenta accreta spectrum (PAS)placenta previa
Beyond the preview
Go deeper on NCT06030492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06030492.